Analyst Price Target is $0.25
▲ +488.24% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for MedMen Enterprises in the last 3 months. The average price target is $0.25, with a high forecast of $0.25 and a low forecast of $0.25. The average price target represents a 488.24% upside from the last price of $0.04.
Current Consensus is
The current consensus among 1 investment analysts is to hold stock in MedMen Enterprises.
MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis retailer in the United States. The company provides products under the MedMen Red and LuxLyte brand names. As of June 25, 2022, it operated 19 stores in California, Nevada, Illinois, Arizona, and Massachusetts. MedMen Enterprises Inc. is based in Los Angeles, California.